Homesecondary progressive ms

  • Roche announces long term disability data for Ocrevus in PPMS patients

    • June 18, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Recent study investigated RRMS to SPMS progression in MS patients

    • June 1, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New Stem cell based treatment investigated for SPMS

    • May 23, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • SPMS patients have higher cognitive decline than RRMS patients, study reports

    • April 17, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Mylan acquires rights for new MS drug

    • April 11, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Roche Acquires regenerative MS therapy program focused on remyelination

    • April 5, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • NATCO launches generic version of Aubagio for MS in INDIA

    • April 5, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Ocrevus shows higher efficacy than Rebif on NEDA in RRMS patients, a recent analysis shows

    • April 2, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • FLX-787 in Multiple Sclerosis displays positive Phase 2 Topline results

    • March 28, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Siponimod significantly improves patient outcomes in SPMS, as per latest study

    • March 23, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more